Immune deficiencies , infection , and systemic immune disorders B-cell reconstitution after lentiviral vector – mediated gene therapy in patients with Wiskott-Aldrich syndrome

Maria Carmina Castiello, PhD, Samantha Scaramuzza, PhD, Francesca Pala, MS, Francesca Ferrua, MD, Paolo Uva, PhD, Immacolata Brigida, PhD, Lucia Sereni, MS, Mirjam van der Burg, PhD, Giorgio Ottaviano, MD, Michael H. Albert, MD, Maria Grazia Roncarolo, MD, Luigi Naldini, MD, PhD, Alessandro Aiuti, MD, PhD, Anna Villa, MD, and Marita Bosticardo, PhD Milan, Cagliari, and Rome, Italy, Rotterdam, The Netherlands, and Munich, Germany

[1]  J. Gern,et al.  Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients With Wiskott-Aldrich Syndrome , 2014, Pediatrics.

[2]  M. van der Burg,et al.  Wiskott–Aldrich Syndrome protein deficiency perturbs the homeostasis of B-cell compartment in humans☆ , 2014, Journal of autoimmunity.

[3]  J. Ritz,et al.  Post-transplantation B cell activating factor and B cell recovery before onset of chronic graft-versus-host disease. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  Michael Rothe,et al.  Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity , 2014, Science Translational Medicine.

[5]  F. Candotti,et al.  Molecular and phenotypic abnormalities of B lymphocytes in patients with Wiskott-Aldrich syndrome. , 2014, The Journal of allergy and clinical immunology.

[6]  M. van der Burg,et al.  B-cell development and functions and therapeutic options in adenosine deaminase-deficient patients. , 2014, The Journal of allergy and clinical immunology.

[7]  F. Candotti.  Gene transfer into hematopoietic stem cells as treatment for primary immunodeficiency diseases , 2014, International Journal of Hematology.

[8]  R. Elhasid,et al.  Impact of Conditioning on Outcome of Hematopoietic Stem Cell Transplantation for Wiskott-Aldrich Syndrome , 2013, Journal of pediatric hematology/oncology.

[9]  E. Haddad,et al.  B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment? , 2013, The Journal of allergy and clinical immunology.

[10]  E. Meffre,et al.  Expansion of autoreactive unresponsive CD21-/low B cells in Sjögren's syndrome-associated lymphoproliferation. , 2013, Arthritis and rheumatism.

[11]  A. Fischer,et al.  Characteristics and outcome of early-onset, severe forms of Wiskott-Aldrich syndrome. , 2013, Blood.

[12]  M. C. Castiello,et al.  Autoimmunity in Wiskott–Aldrich Syndrome: An Unsolved Enigma , 2012, Front. Immun..

[13]  F. Alt,et al.  Wiskott-Aldrich syndrome protein (WASP) and N-WASP are critical for peripheral B-cell development and function. , 2012, Blood.

[14]  A. Rolink,et al.  BAFF‐R expression correlates with positive selection of immature B cells , 2012, European journal of immunology.

[15]  V. Lougaris,et al.  Soluble BAFF Levels Inversely Correlate with Peripheral B Cell Numbers and the Expression of BAFF Receptors , 2012, The Journal of Immunology.

[16]  E. Meffre.  The establishment of early B cell tolerance in humans: lessons from primary immunodeficiency diseases , 2011, Annals of the New York Academy of Sciences.

[17]  A. Fischer,et al.  Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study. , 2011, Blood.

[18]  L. Naldini,et al.  Lentiviral-mediated gene therapy leads to improvement of B-cell functionality in a murine model of Wiskott-Aldrich syndrome. , 2011, The Journal of allergy and clinical immunology.

[19]  F. Candotti,et al.  Nuclear Role of WASp in the Pathogenesis of Dysregulated TH1 Immunity in Human Wiskott-Aldrich Syndrome , 2010, Science Translational Medicine.

[20]  C. Cunningham-Rundles,et al.  Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. , 2010, Blood.

[21]  N. Shan,et al.  The effects of BAFF and BAFF-R-Fc fusion protein in immune thrombocytopenia. , 2009, Blood.

[22]  M. Cancro.  Signalling crosstalk in B cells: managing worth and need , 2009, Nature Reviews Immunology.

[23]  K. Schwarz,et al.  Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells , 2009, Proceedings of the National Academy of Sciences.

[24]  A. Villa,et al.  Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. , 2009, Blood.

[25]  L. Notarangelo,et al.  WASP confers selective advantage for specific hematopoietic cell populations and serves a unique role in marginal zone B-cell homeostasis and function. , 2008, Blood.

[26]  N. Olsen,et al.  Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes , 2006, Clinical and experimental immunology.

[27]  H. Nossent,et al.  B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time , 2006, Lupus.

[28]  H. Ochs,et al.  The Wiskott-Aldrich Syndrome Protein Regulates Nuclear Translocation of NFAT2 and NF-κB (RelA) Independently of Its Role in Filamentous Actin Polymerization and Actin Cytoskeletal Rearrangement1 , 2005, The Journal of Immunology.

[29]  E. Remold-O’Donnell,et al.  Phenotypic perturbation of B cells in the Wiskott–Aldrich syndrome , 2005, Clinical and experimental immunology.

[30]  T. Laín de Lera,et al.  Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[31]  V. Roschke,et al.  B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations. , 2003, Arthritis and rheumatism.

[32]  A. Abo,et al.  A Role for Wiskott-Aldrich Syndrome Protein in T-cell Receptor-mediated Transcriptional Activation Independent of Actin Polymerization* , 2001, The Journal of Biological Chemistry.

[33]  C. Goodnow,et al.  A critical role for complement in maintenance of self-tolerance. , 1998, Immunity.

[34]  R de Groot,et al.  Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. , 1997, The Journal of pediatrics.

[35]  L. Notarangelo,et al.  Studies of the expression of the Wiskott-Aldrich syndrome protein. , 1996, The Journal of clinical investigation.

[36]  U. Francke,et al.  Wiskott–Aldrich Syndrome Protein, a Novel Effector for the GTPase CDC42Hs, Is Implicated in Actin Polymerization , 1996, Cell.

[37]  D. Tuveson,et al.  Molecular interactions of complement receptors on B lymphocytes: a CR1/CR2 complex distinct from the CR2/CD19 complex , 1991, The Journal of experimental medicine.

[38]  L. M. Gould,et al.  An evaluation of a solid phase red cell adherence test for detecting platelet-associated IgG in immune thrombocytopenia. , 1990, American journal of clinical pathology.

[39]  O. Tawfik,et al.  A solid-phase red cell adherence test for platelet cross-matching. , 1985, Medical laboratory sciences.

[40]  T. Juji,et al.  Detection of Platelet Antibodies by a Newly Developed Mixed Agglutination with Platelets , 1981, Vox sanguinis.

[41]  L. Harker,et al.  The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets , 1980 .

[42]  A. Erdei,et al.  Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients. , 2013, International immunology.

[43]  C. von Kalle,et al.  Preclinical Safety and Efficacy of Human CD34+ Cells Transduced With Lentiviral Vector for the Treatment of Wiskott-Aldrich Syndrome. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[44]  J. Stockman.  Stem-Cell Gene Therapy for the Wiskott–Aldrich Syndrome , 2012 .

[45]  W. Robinson,et al.  B cells and transplantation: an educational resource. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[46]  A. Fischer,et al.  Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation. , 2008, Blood.

[47]  J. Tschopp,et al.  Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. , 2002, The Journal of clinical investigation.

[48]  Michael Schlesier,et al.  Expansion of CD19(hi)CD21(lo/neg) B cells in common variable immunodeficiency (CVID) patients with autoimmune cytopenia. , 2002, Immunobiology.

[49]  Sue-Jane Lin,et al.  Programmed death-1 (PD-1) defines a transient and dysfunctional oligoclonal T cell population in acute homeostatic proliferation , 2007, The Journal of experimental medicine.